FLUBENOL 5 % W/W PREMIX FOR MEDICATED FEEDING STUFF
Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
01-05-2015
Деякі документи на цей товар наразі недоступні. Ви можете надіслати запит до нашої служби підтримки, і ми повідомимо вас, як тільки ми зможемо їх отримати.
Відправляти запит.
Відправляти запит.
Активний інгредієнт:
FLUBENDAZOLE
Доступна з:
Elanco Animal Health, Eli Lilly and Company Limited
Код атс:
QP52AC12
ІПН (Міжнародна Ім'я):
FLUBENDAZOLE
Дозування:
5 %w/w
Фармацевтична форма:
Premix for Med.Feedstuffs
Тип рецепту:
POM
Терапевтична група:
Fowl - Chicken, Fowl, Fowl - Turkey, Porcine
Терапевтична области:
Flubendazole
Терапевтичні свідчення:
Endoparasiticide
Статус Авторизація:
Authorised
Дата Авторизація:
2012-05-25
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Flubenol 5 % w/w Premix for Medicated Feeding Stuff
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff.
White powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pig and Poultry.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Flubendazole is a broad spectrum anthelmintic, effective against mature and immature stages of the following nematodes
of the gastro-intestinal and respiratory tract:
In pigs: _Ascaris suum, _(large roundworm) including migrating larvae, _Hyostrongylus rubidus, _(red stomach worm),
_Oesophagostomum dentatum _(nodular worm). _Trichuris suis _(whipworm), _Strongyloides ransomi _(adult) and
_Metastrongylus apri _(lungworm).
In poultry: _Syngamus trachea, Ascaridia galli, Heterakis gallinarum, Capillaria gallinarum, Amidostomum anseris,_
_Trichostrongylus tenuis._
Flubendazole is ovicidal.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredient.
Each g contains:
Active substance
Flubendazole
50 mg
Excipients
Titanium Dioxide (E171) 20 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/04/2015_
_CRN 7020460_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they increase the risk of development of resistance and
could ultimately result in ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
•
Underdosing.
Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faec
Прочитайте повний документ
